May 07, 2025

COVID-19 Vaccination May Lower Fibromyalgia Risk, Study

A large matched-cohort study found that COVID-19 vaccination was linked to a reduced risk of developing fibromyalgia among survivors, particularly in men and those with depression or anxiety.

Conexiant

May 05, 2025

FDA Monthly Round-up: Key April Updates

April’s FDA approvals feature first-in-class therapies, targeted biologics, expanded indications, and innovative delivery systems across allergy, endocrinology, rheumatology, oncology, infectious diseases, and more.

Conexiant

May 01, 2025

Race, Sex Gaps Reshape Hearing Loss Landscape

A new study reveals significant disparities in hearing loss prevalence: 60.7% of White males are affected, compared with 29.2% of Black females.

Conexiant

April 30, 2025

FDA Approves FcRn Blocker for Broad gMG Use

The first FcRn blocker for both adult and pediatric generalized myasthenia gravis has been approved by the FDA, based on data showing sustained symptom improvement and IgG reduction in clinical trials.

Conexiant

April 28, 2025

High Dose Vitamin D May Reduce MS Activity

Vitamin D significantly reduced disease activity in clinically isolated syndrome and early relapsing-remitting multiple sclerosis in the D-Lay MS trial.

Conexiant

April 28, 2025

High Dose Vitamin D May Reduce MS Activity

Vitamin D significantly reduced disease activity in clinically isolated syndrome and early relapsing-remitting multiple sclerosis in the D-Lay MS trial.

Conexiant

April 28, 2025

Esketamine Plus SNRI Cuts Relapse, Study

Real-world study finds esketamine combined with an SNRI linked to lower mortality, hospitalization, and relapse rates compared to esketamine plus SSRI in treatment-resistant depression.

Conexiant

April 28, 2025

DaT Imaging Tracks Parkinson’s Motor Symptom Progression

A large Parkinson’s study found that a decline in dopamine transporter signals in the less affected putamen tracks worsening motor symptoms, supporting the use of DaT imaging for monitoring disease progression.

Conexiant

April 25, 2025

Opioid Use High in Adults With Cerebral Palsy 

Over 50% exhibited a mixed pain phenotype, researchers wrote, linking cerebral palsy pain types to increased opioid use and treatment complexity.

Conexiant